Tag Archives: LIMR

Clinical Trial of the Week: Treatment trial for men with localized intermediate-risk prostate cancer

By Donna Loyle, communications specialist, LIMR Main Line Health researchers are conducting a treatment trial for men diagnosed with stage IIA-B prostate cancer. Study #NRG GU005 is a phase III clinical trial that seeks to determine the safety and efficacy … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Device study for patients with severe mitral valve regurgitation

By Donna Loyle, communications specialist, LIMR The APOLLO clinical trial (#3809) is for patients who’ve been diagnosed with severe symptomatic mitral regurgitation and who’ve been told they need mitral valve replacement. This is a multi-center, global, prospective, interventional, pre-market trial … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Study of financial burden in patients diagnosed with colorectal cancer

By Donna Loyle, communications specialist, LIMR Researchers seek patients who have been diagnosed with stage I-III colon or rectal cancer and who will undergo treatment. The study examines the financial burden of cancer care on patients. Collecting data from patients … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Study of Chemotherapy With or Without Radiation Therapy for Patients with Non-Small Cell Lung Cancer

By Donna Loyle, communications specialist, LIMR Researchers are recruiting patients who’ve been diagnosed with stage 4 non-small cell lung cancer (NSCLC) for a phase II/III randomized study. The goal is to discern if maintenance chemotherapy and stereotactic body radiation therapy … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Adjuvant lung cancer enrichment marker identification and sequencing trial

By Donna Loyle, communications specialist, LIMR The ALCHEMIST trial, available at all Main Line Health acute care hospitals, seeks to identify genetic mutations in patients diagnosed with non-small cell lung cancer (NSCLC). To participate in this research trial, patients must … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: New, post-surgical treatment trial for patients diagnosed with grade II meningioma

 By Donna Loyle, communications specialist, LIMR Researchers are enrolling patients in a brand-new treatment trial of patients who’ve been diagnosed with grade II meningioma and whose tumor has been surgically removed. Researchers seek to determine if radiation therapy (RT) can … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for patients diagnosed with node-positive or high-risk node-negative, triple-negative invasive breast cancer

By Donna Loyle, communications specialist, LIMR Study #BR003 is a randomized phase III trial of adjuvant therapy comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative, triple-negative invasive breast cancer. There are … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Weight-Loss Study for Breast Cancer Patients

By Donna Loyle, communications specialist, LIMR The breast cancer weight-loss study (called the BWEL trial) is for patients who’ve been diagnosed within the past 12 months with stage 2 or 3 breast cancer and are interested in losing weight. Researchers … Continue reading

Posted in Clinician News | Tagged | Leave a comment

LIMR researchers hail 2018 Nobel Prize winners for their pioneering work in cancer immunotherapy

Researchers at the Lankenau Institute for Medical Research (LIMR) congratulate the winners of the 2018 Nobel Prize in Physiology or Medicine, James P. Allison of the United States and Tasuku Honjo of Japan. The Nobel Prize Committee recognized the researchers’ … Continue reading

Posted in Clinician News | Tagged | Leave a comment

LIMR researchers uncover potential new therapy for ulcerative colitis

Researchers at the Lankenau Institute for Medical Research (LIMR) have isolated an antibody that may offer a new strategy to treat ulcerative colitis (UC). UC affects about 907,000 Americans, according to the Crohn’s and Colitis Foundation of America. The disease … Continue reading

Posted in Clinician News | Tagged | Leave a comment